par 545 (Ranitidine 300 mg)
Pill imprint par 545 has been identified as Ranitidine hydrochloride 300 mg.
Ranitidine is used in the treatment of gerd; indigestion; duodenal ulcer; zollinger-ellison syndrome; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for par 545 (Ranitidine 300 mg)
- 300 mg
- 14.00 mm
- Elliptical / Oval
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- FD&C Yellow No. 6
pregelatinized corn starch
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|62584-0253||Amerisource Health Services|
|54868-4350||Physicians Total Care Inc (repackager)|
|49999-0428||Lake Erie Medical and Surgical Supply (repackager)|
|68115-0404||Dispensexpress Inc (repackager)|
|63874-0428||Altura Pharmaceuticals Inc (repackager)|
|66267-0452||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
Ranitidine hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...